IMM 0.00% 40.0¢ immutep limited

"waiting on interim Phase IIb data"As per current analyst report...

  1. 4,906 Posts.
    lightbulb Created with Sketch. 343




    "waiting on interim Phase IIb data"


    As per current analyst report page 11 "if any". Maybe a fundamentalist here could 'phone a friend' just to confirm,yes interim data will be released to the market this month or no, not until July 2013, two years after the final patient has received their first injection??



    ""There is the potential for near term data on CVac efficacy. The IIb trial
    vaccinates patients every four weeks for 24 weeks, followed by booster
    injections every eight weeks until week 48. The aim of the trial will be to
    generate superior data on Progression Free Survival compared to standard of
    care. We understand that PRR has included in the IIb trial protocol an ?interim
    data point? in which the company can look at the data to see if the trial is
    sufficiently powered. We expect that interim data, if any, could be available
    within a year of first dose, that is, around July 2011;""
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.000(0.00%)
Mkt cap ! $581.0M
Open High Low Value Volume
40.0¢ 41.0¢ 39.5¢ $1.515M 3.783M

Buyers (Bids)

No. Vol. Price($)
4 115519 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 37481 2
View Market Depth
Last trade - 16.10pm 11/09/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.